Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Translating Human Prototype Liver Implant Technology from Academia to Industry for Third-Party Transplant and In Vivo Validation.

Cells·2026
Same author

Glycosaminoglycans in tissue regeneration: Insights into glycobiology and their biomedical application.

Bioactive materials·2026
Same author

Radiology-based artificial intelligence for predicting targeted therapy response in pan-cancer: a comprehensive review.

Journal of translational medicine·2025
Same author

Ultrafast crosslinking, strongly adhesive <i>de novo</i> protein hydrogels promote cartilage regeneration.

Bioactive materials·2025
Same author

Transcriptomic Profiling of iPS Cell-Derived Hepatocyte-like Cells Reveals Their Close Similarity to Primary Liver Hepatocytes.

Cells·2025
Same author

Genome editing of TXNIP in human pluripotent stem cells for the generation of hepatocyte-like cells and insulin-producing islet-like aggregates.

Stem cell research & therapy·2025

Related Experiment Video

Updated: Jun 12, 2025

Using Human Induced Pluripotent Stem Cell-derived Hepatocyte-like Cells for Drug Discovery
12:40

Using Human Induced Pluripotent Stem Cell-derived Hepatocyte-like Cells for Drug Discovery

Published on: May 19, 2018

10.2K

Screening a Compound Library to Identify Additives That Boost Cytochrome P450 Enzyme Function in Vascularised Liver

Baltasar Lucendo-Villarin1, Yu Wang1, Sunil K Mallanna2,3

  • 1Centre for Regenerative Medicine, Institute for Regeneration and Repair, The University of Edinburgh, Edinburgh BioQuarter, Edinburgh EH16 4UU, UK.

Cells
|September 27, 2024
PubMed
Summary
This summary is machine-generated.

Researchers screened compounds to find additives that enhance the metabolic function of engineered human liver tissue. This work aims to improve drug metabolism prediction in stem cell-derived models for safer drug development.

Keywords:
hepatocyte functionliverpluripotent stem cellregenerative medicinescreeningsmall molecules

More Related Videos

Author Spotlight: A Selective Luciferase-Based Assay for Monitoring ATG4B 27 Activity in Cells
09:51

Author Spotlight: A Selective Luciferase-Based Assay for Monitoring ATG4B 27 Activity in Cells

Published on: June 30, 2023

768
Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures
10:44

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures

Published on: March 28, 2017

9.8K

Related Experiment Videos

Last Updated: Jun 12, 2025

Using Human Induced Pluripotent Stem Cell-derived Hepatocyte-like Cells for Drug Discovery
12:40

Using Human Induced Pluripotent Stem Cell-derived Hepatocyte-like Cells for Drug Discovery

Published on: May 19, 2018

10.2K
Author Spotlight: A Selective Luciferase-Based Assay for Monitoring ATG4B 27 Activity in Cells
09:51

Author Spotlight: A Selective Luciferase-Based Assay for Monitoring ATG4B 27 Activity in Cells

Published on: June 30, 2023

768
Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures
10:44

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures

Published on: March 28, 2017

9.8K

Area of Science:

  • Hepatology and Regenerative Medicine
  • Drug Metabolism and Pharmacokinetics
  • Stem Cell Biology

Background:

  • Accurate in vitro models are crucial for studying human organ function and disease.
  • Liver damage, often from adverse drug reactions, poses significant health risks.
  • Current models struggle to fully replicate human liver physiology and drug metabolism.

Purpose of the Study:

  • To identify compounds that enhance the metabolic function of stem cell-derived liver tissue.
  • To improve the maturity and predictive accuracy of in vitro liver models.
  • To optimize neonatal and adult cytochrome P450 function in engineered liver tissues.

Main Methods:

  • Screening of a compound library to identify potential additives.
  • Utilizing in vitro-engineered human liver tissue models derived from stem cells.
  • Assessing the impact of identified compounds on tissue maturity and metabolic function.

Main Results:

  • Identification of specific compounds that improve the maturity of engineered liver tissue.
  • Demonstrated potential for fine-tuning cytochrome P450 metabolic activity in vitro.
  • Established a screening strategy for optimizing stem cell-derived liver models.

Conclusions:

  • The identified compounds show promise for enhancing the metabolic capabilities of engineered human liver tissues.
  • This approach can lead to more predictive in vitro models for drug metabolism and safety assessment.
  • Further development could significantly improve the drug development process by reducing late-stage failures due to unforeseen toxicity.